vs
Side-by-side financial comparison of MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) and Orchid Island Capital, Inc. (ORC). Click either name above to swap in a different company.
MARAVAI LIFESCIENCES HOLDINGS, INC. is the larger business by last-quarter revenue ($49.9M vs $38.5M, roughly 1.3× Orchid Island Capital, Inc.). Orchid Island Capital, Inc. runs the higher net margin — 268.7% vs -71.6%, a 340.3% gap on every dollar of revenue. On growth, Orchid Island Capital, Inc. posted the faster year-over-year revenue change (372.6% vs -11.8%). Over the past eight quarters, Orchid Island Capital, Inc.'s revenue compounded faster (301.6% CAGR vs -11.9%).
Maravai LifeSciences Holdings is a global life sciences firm developing critical reagents, diagnostic products, and tech solutions to support biopharma research, drug development, clinical diagnostics, and cell/gene therapy manufacturing. It serves biotech, pharma, research bodies and labs worldwide across three core segments.
Orchid Island Capital, Inc. is a U.S.-based specialty finance company operating as a real estate investment trust. It primarily invests in residential mortgage-backed securities, including agency and non-agency products, targeting consistent risk-adjusted returns for its investors across U.S. fixed income markets.
MRVI vs ORC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $49.9M | $38.5M |
| Net Profit | $-35.7M | $103.4M |
| Gross Margin | 25.8% | — |
| Operating Margin | -117.9% | — |
| Net Margin | -71.6% | 268.7% |
| Revenue YoY | -11.8% | 372.6% |
| Net Profit YoY | -37.7% | 1764.9% |
| EPS (diluted) | $-0.24 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $49.9M | $38.5M | ||
| Q3 25 | $41.6M | $26.9M | ||
| Q2 25 | $47.4M | $23.2M | ||
| Q1 25 | $46.9M | $19.7M | ||
| Q4 24 | $56.6M | — | ||
| Q3 24 | $69.0M | $340.0K | ||
| Q2 24 | $69.4M | $-697.0K | ||
| Q1 24 | $64.2M | $-2.5M |
| Q4 25 | $-35.7M | $103.4M | ||
| Q3 25 | $-25.6M | $72.1M | ||
| Q2 25 | $-39.6M | $-33.6M | ||
| Q1 25 | $-29.9M | $17.1M | ||
| Q4 24 | $-25.9M | — | ||
| Q3 24 | $-97.1M | $17.3M | ||
| Q2 24 | $-9.8M | $-5.0M | ||
| Q1 24 | $-12.1M | $19.8M |
| Q4 25 | 25.8% | — | ||
| Q3 25 | 13.6% | — | ||
| Q2 25 | 16.4% | — | ||
| Q1 25 | 16.5% | — | ||
| Q4 24 | 34.3% | — | ||
| Q3 24 | 46.7% | — | ||
| Q2 24 | 44.4% | — | ||
| Q1 24 | 40.3% | — |
| Q4 25 | -117.9% | — | ||
| Q3 25 | -98.6% | — | ||
| Q2 25 | -139.8% | — | ||
| Q1 25 | -104.9% | — | ||
| Q4 24 | -66.7% | — | ||
| Q3 24 | -239.9% | — | ||
| Q2 24 | -19.4% | — | ||
| Q1 24 | -29.4% | — |
| Q4 25 | -71.6% | 268.7% | ||
| Q3 25 | -61.4% | 267.8% | ||
| Q2 25 | -83.5% | -145.0% | ||
| Q1 25 | -63.9% | 86.9% | ||
| Q4 24 | -45.8% | — | ||
| Q3 24 | -140.6% | 5094.1% | ||
| Q2 24 | -14.1% | 714.3% | ||
| Q1 24 | -18.8% | -794.2% |
| Q4 25 | $-0.24 | — | ||
| Q3 25 | $-0.18 | — | ||
| Q2 25 | $-0.27 | — | ||
| Q1 25 | $-0.21 | — | ||
| Q4 24 | $-0.21 | — | ||
| Q3 24 | $-0.68 | — | ||
| Q2 24 | $-0.07 | — | ||
| Q1 24 | $-0.09 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $216.9M | $665.9M |
| Total DebtLower is stronger | $291.8M | — |
| Stockholders' EquityBook value | $212.4M | $1.4B |
| Total Assets | $770.6M | $11.7B |
| Debt / EquityLower = less leverage | 1.37× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $216.9M | $665.9M | ||
| Q3 25 | $243.6M | $583.9M | ||
| Q2 25 | $269.9M | $440.8M | ||
| Q1 25 | $285.1M | $396.4M | ||
| Q4 24 | $322.4M | — | ||
| Q3 24 | $578.2M | $322.1M | ||
| Q2 24 | $573.2M | $241.0M | ||
| Q1 24 | $561.7M | $190.4M |
| Q4 25 | $291.8M | — | ||
| Q3 25 | $292.8M | — | ||
| Q2 25 | $293.9M | — | ||
| Q1 25 | $294.9M | — | ||
| Q4 24 | $295.9M | — | ||
| Q3 24 | $521.7M | — | ||
| Q2 24 | $522.5M | — | ||
| Q1 24 | $523.3M | — |
| Q4 25 | $212.4M | $1.4B | ||
| Q3 25 | $245.4M | $1.1B | ||
| Q2 25 | $265.9M | $912.0M | ||
| Q1 25 | $300.6M | $855.9M | ||
| Q4 24 | $325.3M | — | ||
| Q3 24 | $344.9M | $656.0M | ||
| Q2 24 | $434.7M | $555.9M | ||
| Q1 24 | $410.7M | $481.6M |
| Q4 25 | $770.6M | $11.7B | ||
| Q3 25 | $849.2M | $9.1B | ||
| Q2 25 | $897.0M | $7.6B | ||
| Q1 25 | $959.8M | $7.3B | ||
| Q4 24 | $1.0B | — | ||
| Q3 24 | $1.3B | $5.9B | ||
| Q2 24 | $1.4B | $4.9B | ||
| Q1 24 | $1.4B | $4.2B |
| Q4 25 | 1.37× | — | ||
| Q3 25 | 1.19× | — | ||
| Q2 25 | 1.11× | — | ||
| Q1 25 | 0.98× | — | ||
| Q4 24 | 0.91× | — | ||
| Q3 24 | 1.51× | — | ||
| Q2 24 | 1.20× | — | ||
| Q1 24 | 1.27× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-22.8M | $120.4M |
| Free Cash FlowOCF − Capex | $-24.9M | — |
| FCF MarginFCF / Revenue | -49.9% | — |
| Capex IntensityCapex / Revenue | 4.2% | — |
| Cash ConversionOCF / Net Profit | — | 1.16× |
| TTM Free Cash FlowTrailing 4 quarters | $-70.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-22.8M | $120.4M | ||
| Q3 25 | $-15.2M | $28.0M | ||
| Q2 25 | $-10.3M | $18.4M | ||
| Q1 25 | $-9.4M | $25.8M | ||
| Q4 24 | $-14.6M | — | ||
| Q3 24 | $13.1M | $-14.8M | ||
| Q2 24 | $17.4M | $19.3M | ||
| Q1 24 | $-8.5M | $45.0M |
| Q4 25 | $-24.9M | — | ||
| Q3 25 | $-18.1M | — | ||
| Q2 25 | $-13.1M | — | ||
| Q1 25 | $-14.6M | — | ||
| Q4 24 | $-20.5M | — | ||
| Q3 24 | $4.5M | — | ||
| Q2 24 | $7.9M | — | ||
| Q1 24 | $-14.1M | — |
| Q4 25 | -49.9% | — | ||
| Q3 25 | -43.4% | — | ||
| Q2 25 | -27.7% | — | ||
| Q1 25 | -31.2% | — | ||
| Q4 24 | -36.2% | — | ||
| Q3 24 | 6.6% | — | ||
| Q2 24 | 11.4% | — | ||
| Q1 24 | -22.0% | — |
| Q4 25 | 4.2% | — | ||
| Q3 25 | 7.0% | — | ||
| Q2 25 | 6.1% | — | ||
| Q1 25 | 11.2% | — | ||
| Q4 24 | 10.3% | — | ||
| Q3 24 | 12.4% | — | ||
| Q2 24 | 13.8% | — | ||
| Q1 24 | 8.8% | — |
| Q4 25 | — | 1.16× | ||
| Q3 25 | — | 0.39× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.51× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -0.86× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 2.28× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MRVI
| Cygnus Segment | $27.2M | 54% |
| Other | $18.4M | 37% |
| Shipping And Handling | $4.3M | 9% |
ORC
Segment breakdown not available.
